Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005313704
Fri, 09.02.2024
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
Decline in profit due to expected weaker product mix
JENA, 9 February 2024
Carl Zeiss Meditec generated revenue of €475.0m in the first quarter of fiscal year 2023/24 (prior year: €470.3m), corresponding to a growth of +1.0% (adjusted for currency effects: +3.3%) [ … ]
Mon, 29.01.2024
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
Jena, 29 January 2024
The Management Board of Carl Zeiss Meditec AG (ISIN: DE0005313704) has, with the approval of the Supervisory Board today, agreed to launch a share buyback program. Under the share buyback program, own shares will be purchased f [ … ]
Thu, 11.01.2024
Carl Zeiss Meditec AG
U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.
DUBLIN, CA (USA) / JENA, Germany | January 11, 2024 | Carl Zeiss Meditec AG
ZEISS Medical Technology announced today tha [ … ]
Fri, 15.12.2023
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)Acquisition will extend the company’s leadership in ophthalmic medical devices market and expands its position in the vitreo-retinal surgery segment
Jena/Deutschland | Dec. 15, 2023 | Carl Zeiss Meditec AG
Carl Zeiss Meditec AG announced today t [ … ]
Fri, 15.12.2023
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
Jena, December 15, 2023
Carl Zeiss Meditec AG (ISIN: DE0005313704) announces today that it has entered into a definitive agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center (International) BV, Zuidland, Netherlands (D.O.R.C.), from the investment firm [ … ]
Tue, 12.12.2023
Carl Zeiss Meditec AG
Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent
Additional market shares were gained despite challenging macroeconomic conditions
JENA, 12 December 2023
Carl Zeiss Meditec generated revenue of €2,089m in fiscal year 2022/23 (prior year: €1,903m), corresponding to growth of +9.8% (adjusted for currency ef [ … ]
Fri, 04.08.2023
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves further strong revenue growth after nine months of fiscal year 2022/23 with continued high strategic investments
JENA, 4 August 2023
Carl Zeiss Meditec generated revenue of around €1,509.6m in the first nine months of fiscal year 2022/23 (prior year: €1,332.9m) - growth of +13.3% (adjusted for currency effects: +12.9% [ … ]
Tue, 09.05.2023
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings
Unfavorable product mix and increase in operating costs impact EBIT margin
JENA, 9 May 2023
Carl Zeiss Meditec generated revenue of around €974.5m in the first six months of fiscal year 2022/23 (prior year: €855.4m), equating to growth of [ … ]
Tue, 09.05.2023
Carl Zeiss Meditec AG
Carl Zeiss Meditec achieves double-digit growth in first half year of 2022/23 with declining earnings
Unfavorable product mix and increase in operating costs impact EBIT margin
JENA, 9 May 2023
Carl Zeiss Meditec generated revenue of around €974.5m in the first six months of fiscal year 2022/23 (prior year: €855.4m), equating to growth of [ … ]
Wed, 19.04.2023
Carl Zeiss Meditec AG
Forecast for fiscal year 2022/23 refined – Targeting widened and reduced range for EBIT margin – Further growth with reduced earnings in first half year of 2022/23
Jena, April 19, 2023
In the first half of fiscal year 2022/23, Carl Zeiss Meditec AG (ISIN: DE0005313704) had revenues of € 974.5 million (prior year: € 855.4 million). Operati [ … ]